Everwell Health announced Thursday that two executive leaders recently joined the organization, which further strengthens the company’s innovation capabilities and supports its long-term growth strategy. Volkan Eren has assumed the newly created role of vice president, sales and business development, while Catherine Kwik-Uribe will serve as vice president of scientific and regulatory affairs.
Eren will head the sales team and lead commercial strategy and sales administration. Eren joins the organization from a unique background with fast-paced entrepreneurial businesses like Enzymotec, along with experience and roles of increased responsibility leading sales teams at larger scaled companies like Frutarom and IFF. Eren’s prior role at IFF was sales leader for supplements, food & beverages and will focus on business expansion and diversification, as well as leading the sales organization.
Kwik-Uribe is responsible for maintaining the excellent reputation that Nutrition21, Everwell Health’s first platform investment, has earned throughout the years, while creating new strategies to build expertise, ideas and processes that support the platform’s “science-first” approach. Kwik-Uribe comes from a successful career at Mars Inc., her most recent role as vice president, scientific & regulatory affairs, applied science & nutrition, for Mars Edge. Kwik-Uribe has worked across multiple product categories and led scientific teams of all sizes, conducted extensive research in human health and nutrition, and led the translation of science into consumer-relevant claims. Her expertise will drive the company’s clinical research needs and support new product claims and regulatory approvals in the U.S and international markets.
Both executives also bring mergers & acquisitions experience that will be important as Everwell Health invests to expand the platform.
Steve Rosenman, CEO of Everwell Health, commented: “These new leaders complement our existing team at Nutrition21. Their experience and success, both at nimble, high-growth companies and at highly professional, scaled global enterprises will support Everwell Health’s dual growth strategy of optimizing organic opportunities at Nutrition21, while aggressively developing strategic partnerships and pursuing external business development. These roles align with our commitments and continued investments in science, and in capabilities to serve our customers and help them grow.”
